4-3074876-CCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAG-CCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAG

Variant summary

Our verdict is Benign. The variant received -11 ACMG points: 0P and 11B. BP3BP6_ModerateBS1BS2

The NM_001388492.1(HTT):​c.105_110dupGCAGCA​(p.Gln36_Gln37dup) variant causes a disruptive inframe insertion change. Variant has been reported in ClinVar as Likely benign (★).

Frequency

Genomes: 𝑓 0.039 ( 121 hom., cov: 0)
Exomes 𝑓: 0.032 ( 2534 hom. )

Consequence

HTT
NM_001388492.1 disruptive_inframe_insertion

Scores

Not classified

Clinical Significance

Likely benign criteria provided, single submitter B:1

Conservation

PhyloP100: 4.84

Publications

6 publications found
Variant links:
Genes affected
HTT (HGNC:4851): (huntingtin) Huntingtin is a disease gene linked to Huntington's disease, a neurodegenerative disorder characterized by loss of striatal neurons. This is thought to be caused by an expanded, unstable trinucleotide repeat in the huntingtin gene, which translates as a polyglutamine repeat in the protein product. A fairly broad range of trinucleotide repeats (9-35) has been identified in normal controls, and repeat numbers in excess of 40 have been described as pathological. The huntingtin locus is large, spanning 180 kb and consisting of 67 exons. The huntingtin gene is widely expressed and is required for normal development. It is expressed as 2 alternatively polyadenylated forms displaying different relative abundance in various fetal and adult tissues. The larger transcript is approximately 13.7 kb and is expressed predominantly in adult and fetal brain whereas the smaller transcript of approximately 10.3 kb is more widely expressed. The genetic defect leading to Huntington's disease may not necessarily eliminate transcription, but may confer a new property on the mRNA or alter the function of the protein. One candidate is the huntingtin-associated protein-1, highly expressed in brain, which has increased affinity for huntingtin protein with expanded polyglutamine repeats. This gene contains an upstream open reading frame in the 5' UTR that inhibits expression of the huntingtin gene product through translational repression. [provided by RefSeq, Jul 2016]
HTT Gene-Disease associations (from GenCC):
  • Huntington disease
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae), Orphanet
  • Lopes-Maciel-Rodan syndrome
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • juvenile Huntington disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -11 ACMG points.

BP3
Nonframeshift variant in repetitive region in NM_001388492.1
BP6
Variant 4-3074876-C-CCAGCAG is Benign according to our data. Variant chr4-3074876-C-CCAGCAG is described in ClinVar as [Likely_benign]. Clinvar id is 3910356.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0388 (5117/131854) while in subpopulation AFR AF = 0.0451 (1603/35518). AF 95% confidence interval is 0.0433. There are 121 homozygotes in GnomAd4. There are 2422 alleles in the male GnomAd4 subpopulation. Median coverage is 0. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 121 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HTTNM_001388492.1 linkc.105_110dupGCAGCA p.Gln36_Gln37dup disruptive_inframe_insertion Exon 1 of 67 ENST00000355072.11 NP_001375421.1
HTTNM_002111.8 linkc.105_110dupGCAGCA p.Gln36_Gln37dup disruptive_inframe_insertion Exon 1 of 67 NP_002102.4 P42858

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HTTENST00000355072.11 linkc.105_110dupGCAGCA p.Gln36_Gln37dup disruptive_inframe_insertion Exon 1 of 67 1 NM_001388492.1 ENSP00000347184.5 P42858

Frequencies

GnomAD3 genomes
AF:
0.0389
AC:
5122
AN:
131756
Hom.:
121
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.0453
Gnomad AMI
AF:
0.0138
Gnomad AMR
AF:
0.0394
Gnomad ASJ
AF:
0.0254
Gnomad EAS
AF:
0.0128
Gnomad SAS
AF:
0.0223
Gnomad FIN
AF:
0.0250
Gnomad MID
AF:
0.0224
Gnomad NFE
AF:
0.0406
Gnomad OTH
AF:
0.0390
GnomAD4 exome
AF:
0.0318
AC:
38958
AN:
1223798
Hom.:
2534
Cov.:
0
AF XY:
0.0322
AC XY:
19551
AN XY:
607118
show subpopulations
African (AFR)
AF:
0.0301
AC:
776
AN:
25786
American (AMR)
AF:
0.0306
AC:
926
AN:
30256
Ashkenazi Jewish (ASJ)
AF:
0.0224
AC:
509
AN:
22716
East Asian (EAS)
AF:
0.00928
AC:
270
AN:
29088
South Asian (SAS)
AF:
0.0277
AC:
2001
AN:
72150
European-Finnish (FIN)
AF:
0.0304
AC:
987
AN:
32484
Middle Eastern (MID)
AF:
0.0419
AC:
158
AN:
3774
European-Non Finnish (NFE)
AF:
0.0332
AC:
31724
AN:
955770
Other (OTH)
AF:
0.0310
AC:
1607
AN:
51774
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.460
Heterozygous variant carriers
0
1211
2421
3632
4842
6053
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1010
2020
3030
4040
5050
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0388
AC:
5117
AN:
131854
Hom.:
121
Cov.:
0
AF XY:
0.0382
AC XY:
2422
AN XY:
63406
show subpopulations
African (AFR)
AF:
0.0451
AC:
1603
AN:
35518
American (AMR)
AF:
0.0392
AC:
525
AN:
13406
Ashkenazi Jewish (ASJ)
AF:
0.0254
AC:
81
AN:
3190
East Asian (EAS)
AF:
0.0129
AC:
53
AN:
4120
South Asian (SAS)
AF:
0.0220
AC:
86
AN:
3908
European-Finnish (FIN)
AF:
0.0250
AC:
184
AN:
7368
Middle Eastern (MID)
AF:
0.0198
AC:
5
AN:
252
European-Non Finnish (NFE)
AF:
0.0406
AC:
2499
AN:
61476
Other (OTH)
AF:
0.0385
AC:
70
AN:
1816
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.532
Heterozygous variant carriers
0
216
432
648
864
1080
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
58
116
174
232
290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0131
Hom.:
452

ClinVar

Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Benign:1
Feb 16, 2025
Laboratory of Genetics, Children's Clinical University Hospital Latvia
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
4.8
Mutation Taster
=80/20
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs71180116; hg19: chr4-3076603; COSMIC: COSV61863116; COSMIC: COSV61863116; API